The previous page is sending you to https://www.wsaz.com/prnewswire/2021/10/20/fda-expands-approval-dupixent-dupilumab-include-children-aged-6-11-years-with-moderate-to-severe-asthma/.

 If you do not want to visit that page, you can return to the previous page.